Literature DB >> 14084387

CURRENT THERAPEUTICS. 192. PENICILLAMINE.

J M WALSHE.   

Abstract

Entities:  

Keywords:  CHEMISTRY; CHILD; COPPER; CYSTINOSIS; CYSTINURIA; HEPATOLENTICULAR DEGENERATION; LEAD POISONING; MACROGLOBULINEMIA; MERCURY POISONING; PENICILLAMINE; PHARMACOLOGY; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14084387

Source DB:  PubMed          Journal:  Practitioner        ISSN： 0032-6518


× No keyword cloud information.
  4 in total

1.  Biological control of physical properties of tendon adhesions: effect of beta-aminopropionitrile in chickens.

Authors:  J M Craver; J W Madden; E E Peacock
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

Review 2.  Red cell aplasia following prolonged D-penicillamine therapy.

Authors:  J L Gollan; S Hussein; A V Hoffbrand; S Sherlock
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

3.  Metal binding by pharmaceuticals. Part 5. Interaction of Cd(II), Ni(II) and Pb(II) with the intracellular hydrolysis products of the anti-tumour agent ICRF 159 and its inactive homologue ICRF 192.

Authors:  P M May; M J Willes; D R Williams; A M Creighton
Journal:  Agents Actions       Date:  1984-10

4.  Copper kinetics in liver disease.

Authors:  R A Smallwood; B McIlveen; V M Rosenoer; S Sherlock
Journal:  Gut       Date:  1971-02       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.